Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity
Saved in:
Main Authors: | Lynn A.C. Devilée, Abou Bakr M. Salama, Jessica M. Miller, Janice D. Reid, Qinghui Ou, Nourhan M. Baraka, Kamal Abou Farraj, Madiha Jamal, Yibing Nong, Todd K. Rosengart, Andres Douglas, Jonathan Satin, Tamer M.A. Mohamed, James E. Hudson, Riham R.E. Abouleisa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Journal of Molecular and Cellular Cardiology Plus |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772976125000558 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD36-Retinoic Acid- FABP5- PPARδ Signaling Axis Primes Neonatal Cardiomyocytes to Spontaneously Proliferate
by: Abou Bakr Salama, et al.
Published: (2025-06-01) -
On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018-02-01) -
The Effects of Sintering Temperature Variations on Microstructure Changes of LTCC Substrate
by: Alias, Rosidah
Published: (2012) -
Rheological Behaviors and Their Correlation with Printing Performance of Silver Paste for LTCC Tape
by: Alias, Rosidah, et al.
Published: (2012) -
Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
by: Wada A, et al.
Published: (2016-07-01)